SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001403752-21-000021
Filing Date
2021-11-03
Accepted
2021-11-03 16:19:23
Documents
14
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zyme-20211103.htm   iXBRL 8-K 48397
2 EX-99.1 exhibit991q3_2021xpressxre.htm EX-99.1 112197
6 zymeworkslogoa.jpg GRAPHIC 7377
  Complete submission text file 0001403752-21-000021.txt   320452

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zyme-20211103.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zyme-20211103_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zyme-20211103_pre.xml EX-101.PRE 12510
7 EXTRACTED XBRL INSTANCE DOCUMENT zyme-20211103_htm.xml XML 12223
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 211375675
SIC: 2834 Pharmaceutical Preparations